Cold Laser

We use Erchonia PL 3000 Cold Lasers:

The PL3000 is a variable frequency (1hz-1,000hz), single diode 3LT® 635nm wavelength laser.

  • Low-level laser therapy is a safe process of the use of low intensity photonic energy as a treatment modality.

  • Photonic stimuli excite the body’s cells infusing them with energy, with the three primary reactions being, reduction of inflammation, cell regeneration, and increased blood flow.

  • The potential applications of low-level laser are almost limitless, however; to date Erchonia has received market clearance for Neck and Shoulder Pain. Erchonia continues to conduct clinical trials on other applications.

  • Low level laser therapy is a non-invasive, fast and effective modality that has been proven in clinical trials to reduce pain, reduce edema, and promote healing.

  • The depth of penetration is dependent on multiple factors including mass and density, however since low-level laser has been proven in clinical studies to effect subcutaneous cells; the point is low-level laser, does penetrate; as opposed to the heat lamp devices that do not.

  • No, most people do not feel anything. For those that have reported a feeling, it is nothing more than a slight tingling.

  • The mechanics of low low-level laser therapy is administered is based on the indication for use; however, the general process is the probe containing the laser diode(s) are held in place or moved gently over the treatment area at a distance of anywhere from 4” – 12..

  • This is dependent of the application; however, progress is immediately evident.

  • Erchonia 3LT® devices used electric diodes, which are high end, culminated and strictly measured within a plus/minus .05%. LEDs are inexpensive, non-focused wide range light sources. The primary difference is in performance and depth of penetration. Laser diodes penetrate, working subcutaneously, LEDs do not affecting the surface only.

  • The FDA clears for market devices and specific indications for use, this is sometime referred to by persons outside the FDA as “FDA Approval”, although it is a term unacceptable to the FDA. All Erchonia devices have received a FDA market clearance or were self-certified in accordance to FDA regulation.

  • Erchonia Corporation develops, designs, and manufactures devices in accordance to both FDA and International Standards for Medical Device Quality Standards. Prior to release to production, finished devices are tested to Medical Safety Standards for Laser Controls, EMC, and Safety.

  • There are no code regulated contraindications; however, since there are no long term evaluations on certain conditions, Erchonia does not recommend use on pregnant women or persons with a pace maker.

  • No, low-level laser by virtue of design is non-heat producing and does not alter the cell structure. The laser irradiation is non-ionizing, meaning it does not collect in the tissue.

  • Some persons have reported a sense of deep relaxation that may cause drowsiness otherwise there are no known and / or published adverse effects of low-level laser therapy.

Physiological affects are inflammation reduction, pain reduction, and accelerated tissue healing simultaneously.